Cannabis Stock Movers For January 9, 2025
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note
Legal Cannabis May Be Boosted by Alcohol Warning From Surgeon General: Analyst
Canopy Growth Edges Up After Appointing Jorgensen as President
Canopy Growth: M. Brooks Jorgensen Appointed as First-Ever President >CGC
Press Release: Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'
Earnings Call Summary | Canopy Growth(CGC.US) Q2 2025 Earnings Conference
Canada's Organigram Shops for U.S. Pot Businesses With Backing From British American Tobacco
ATB Capital Markets Downgrades Canopy Growth(CGC.US) to Sell Rating, Cuts Target Price to $2.79
Canopy Growth (CGC) Was Downgraded to a Sell Rating at ATB Capital Markets
Canopy Growth Corp Price Target Cut to C$4.00/Share From C$6.00 by ATB Capital
Why Canopy Growth (CGC) Is Among the Best Cannabis Stocks To Invest In?
STORZ & BICKEL Makes History as First Vaporizer Brand to Sponsor NYLON House During Miami Art Week
Dropbox Shares Are Trading Higher After the Company Secured a $2 Billion Term Loan Facility Led by Blackstone, Authorized a $1.2 Billion Share Repurchase Program, and Stated It Expects to Meet or Exceed Q4 and FY 2024 Guidance.
Canopy Growth Stock Rises As Acreage Acquisition Comes To A Close: Retail Eyes More Upside
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surge
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know
Press Release: Canopy Growth and Acreage Confirm Canopy USA's Completed Acquisition of Acreage